Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA for Sjogren's Syndrome
NCT00001598Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- May 1997
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sjogren's syndrome comparing DHEA with Placebo (2 arms). Primary endpoints: Salivary gland function at 7 months and Lacrimal gland function at 6 months. Started May 1997; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT00001598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001598.